The Biden administration proposed a rule on Nov. 26 for Medicare and Medicaid to cover anti-obesity medications that were designed to prevent the development of Type 2 diabetes.
More than 42 percent of U.S. adults and 19 percent of children struggle with obesity, which is now recognized as a chronic, life-threatening disease, according to the National Institutes of Health. Obesity can lead to diabetes, cardiovascular disease, stroke, and cancer.
